Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04585256
Other study ID # 0145-20-RMB
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2020
Est. completion date December 31, 2023

Study information

Verified date January 2023
Source Rambam Health Care Campus
Contact Roy Lauterbach, MD
Phone +972-52-9432416
Email r_lauterbach@rmc.gov.il
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Women at term (over 37 weeks) that are candidates for external cephalic version will be positioned in the trendelenburg position 5 minutes prior to external cephalic version performance and during the procedure. The control group will not be positioned differently than usual. We will evaluate external cephalic version success and compare the 2 groups.


Description:

This is a randomized controlled trial that is designed to compare external cephalic version success between women positioned in the trendelenburg position 5 minutes prior to external cephalic version performance and during the procedure and a control group of women that will lie on their back without special positioning. The women that are eligible for participation will receive a thorough explanation and will sign informed consent.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date December 31, 2023
Est. primary completion date September 30, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Women interested in having external cephalic version at a gestational age of 37+0/7 or more. Exclusion Criteria: - Age 18 and under. - Women with a body mass index 35 or higher. - Women with a previous cesarean section. - Women with premature rupture of membranes. - Women with vaginal bleeding. - Women with a previously failed external cephalic version.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Trendelenburg positioning
Women positioned in the trendelenburg position prior to external cephalic version

Locations

Country Name City State
Israel Rambam health care campus Haifa

Sponsors (1)

Lead Sponsor Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary External cephalic version success The rate of successful external cephalic version Up to 10 minutes from the beginning of external cephalic version.
Secondary Pain Visual analog scale scoring from 0-10 during and following the procedure. Up to 2 hours from the beginning of external cephalic version.
Secondary Placental abruption Rate of clinical placental abruption Up to 1 week from the beginning of external cephalic version.
Secondary Vaginal delivery Rate of vaginal deliveries Up to 4 weeks from the beginning of external cephalic version.
Secondary Cesarean delivery Rate of cesarean deliveries Up to 4 weeks from the beginning of external cephalic version.